18524 results
-
List item
Human medicine European public assessment report (EPAR): Blincyto (updated)
blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015,
, 
, Revision: 13, Authorised, Last updated: 15/06/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Felisecto Plus (updated)
selamectin, sarolaner, Cats
Date of authorisation: 26/04/2019, Revision: 2, Authorised, Last updated: 15/06/2021 -
List item
Human medicine European public assessment report (EPAR): Diacomit (updated)
stiripentol, Myoclonic Epilepsy, Juvenile
Date of authorisation: 03/01/2007,
Date of refusal: 11/02/2009, Revision: 17, Authorised, Last updated: 15/06/2021 -
List item
Human medicine European public assessment report (EPAR): Rixathon (updated)
rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Leukemia, Lymphocytic, Chronic, B-Cell, Wegener Granulomatosis, Microscopic Polyangiitis, Pemphigus
Date of authorisation: 15/06/2017,, 
, Revision: 4, Authorised, Last updated: 15/06/2021
-
List item
Human medicine European public assessment report (EPAR): Tysabri (updated)
natalizumab, Multiple Sclerosis
Date of authorisation: 27/06/2006, Revision: 35, Authorised, Last updated: 15/06/2021 -
List item
Human medicine European public assessment report (EPAR): Aimovig (updated)
erenumab, Migraine Disorders
Date of authorisation: 26/07/2018,, Revision: 6, Authorised, Last updated: 15/06/2021
-
List item
Human medicine European public assessment report (EPAR): Efmody (updated)
hydrocortisone, Adrenal Hyperplasia, Congenital
Date of authorisation: 27/05/2021, Authorised, Last updated: 14/06/2021 -
List item
Human medicine European public assessment report (EPAR): Neparvis (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 26/05/2016,, Revision: 12, Authorised, Last updated: 11/06/2021
-
List item
Human medicine European public assessment report (EPAR): Entresto (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 19/11/2015, Revision: 13, Authorised, Last updated: 11/06/2021 -
List item
Human medicine European public assessment report (EPAR): Skyrizi (updated)
Risankizumab, Psoriasis
Date of authorisation: 26/04/2019,, Revision: 5, Authorised, Last updated: 11/06/2021
-
List item
Human medicine European public assessment report (EPAR): Zejula (updated)
Niraparib (tosilate monohydrate), Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms
Date of authorisation: 16/11/2017,, , Revision: 13, Authorised, Last updated: 11/06/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Tulissin (updated)
tulathromycin, Cattle, Pigs, Sheep
Date of authorisation: 24/04/2020,
, Revision: 2, Authorised, Last updated: 11/06/2021
-
List item
Human medicine European public assessment report (EPAR): DaTSCAN (updated)
ioflupane (123l), Tomography, Emission-Computed, Single-Photon, Lewy Body Disease, Parkinson Disease, Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 23, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Xerava (updated)
eravacycline, Infection, Bacterial Infections
Date of authorisation: 20/09/2018,, Revision: 2, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)
clopidogrel (as hydrogen sulfate), Myocardial Infarction, Acute Coronary Syndrome, Peripheral Vascular Diseases, Stroke
Date of authorisation: 18/02/2015,, Revision: 11, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Targretin (updated)
bexarotene, Lymphoma, T-Cell, Cutaneous
Date of authorisation: 29/03/2001, Revision: 22, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Cometriq (updated)
cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014,, , 
, Revision: 22, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Zalasta (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 27/09/2007,, Revision: 18, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Erelzi (updated)
etanercept, Arthritis, Psoriatic, Psoriasis, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid, Spondylitis, Ankylosing
Date of authorisation: 23/06/2017,, , Revision: 9, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)
clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome, Peripheral Vascular Diseases, Myocardial Infarction, Stroke
Date of authorisation: 27/07/2009,, Revision: 17, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Qtern (updated)
Saxagliptin, dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 15/07/2016, Revision: 7, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Saxenda (updated)
liraglutide, Obesity, Overweight
Date of authorisation: 23/03/2015, Revision: 10, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Odefsey (updated)
emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/06/2016, Revision: 18, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): DuoResp Spiromax (updated)
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): BiResp Spiromax (updated)
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021